India faces a crisis as antimicrobial drugs lose effectiveness against bacteria, causing 4.9 million deaths worldwide in 2019. CSIR-Centre for Cellular and Molecular Biology in Hyderabad advances potential solutions. Manjula Reddy’s group targets E. coli’s survival mechanisms, identifying enzymes crucial for cell wall expansion. Puran Singh Sijwali’s team uncovers enzymes vital for Plasmodium falciparum’s growth in malaria research. Despite challenges in drug discovery, collaborations and innovative tools like molecular docking and AI offer hope. The journey from target identification to drug development is arduous but essential, demanding diverse expertise and robust funding.
Unraveling Drug Resistance: India’s Path to Antimicrobial Innovation
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/04/24103953/US-FDA-and-DCA-GHICC2DJ0.3.jpg-860x484.jpg)